Skip to content
Disclosery

EXANE DERIVATIVES: SEDG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SEDG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 875 SEDG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 875 shares
    Change vs previous 13F -486 shares

    0.14% of the 13F portfolio, value $239,421.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,361 shares
    Change vs previous 13F +93 shares

    0.12% of the 13F portfolio, value $438,714.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,268 shares
    Change vs previous 13F +650 shares

    0.09% of the 13F portfolio, value $355,747.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 618 shares
    Change vs previous 13F -6 shares

    0.04% of the 13F portfolio, value $163,899.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 624 shares
    Change vs previous 13F +10 shares

    0.04% of the 13F portfolio, value $165,583.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 614 shares
    Change vs previous 13F -295 shares

    0.05% of the 13F portfolio, value $176,480.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 909 shares
    Change vs previous 13F not available

    0.09% of the 13F portfolio, value $290,067.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).